CervoMed Inc. CRVO
- neflamapimod — Dementia with Lewy Bodies Phase 2
- neflamapimod — Non-Fluent Variant Primary Progressive Aphasia Phase 2
- neflamapimod — Stroke
- neflamapimod — Amyotrophic Lateral Sclerosis
p38α (1 companies · 4 programs)
Companies with an active program directed at p38α.